Published in J Cancer Res Clin Oncol on November 29, 2013
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma: final results of EORTC 18991, a randomised phase III trial. Lancet (2008) 3.62
Metastatic pattern of malignant melanoma. A study of 216 autopsy cases. Am J Surg (1978) 3.37
Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg (1998) 3.11
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94
Sequential biochemotherapy versus chemotherapy for metastatic melanoma: results from a phase III randomized trial. J Clin Oncol (2002) 2.52
Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol (2004) 2.36
Epidemiology of brain metastases. Curr Oncol Rep (2012) 2.09
Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg (1991) 2.06
Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer (1978) 2.04
Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro Oncol (2008) 1.73
Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival. Cancer (2010) 1.31
Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991. Eur J Cancer (2011) 1.28
Prognostic correlations and response to treatment in advanced metastatic malignant melanoma. Cancer Res (1974) 1.25
Central nervous system metastases in malignant melanoma. Neurosurgery (1981) 1.21
Malignant melanoma brain metastases. Review of Roswell Park Memorial Institute experience. Cancer (1984) 1.14
The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high-risk, lymph node-metastatic melanoma. Cancer (2009) 1.02
Gender and cutaneous melanoma. Br J Dermatol (1997) 0.98
Cerebral metastases from malignant melanoma. Radiother Oncol (1992) 0.94
Relapse in the central nervous system in melanoma patients successfully treated with biomodulators. J Clin Oncol (1989) 0.92
Combined-modality therapy for patients with regional nodal metastases from melanoma. Int J Radiat Oncol Biol Phys (2005) 0.90
Prognostic factors and impact of treatment in melanoma brain metastases: better prognosis for women? Dermatology (2007) 0.87
Malignant melanoma. Inflammatory mononuclear cell infiltrates in cerebral metastases during concurrent therapy with viral oncolysate. Cancer (1986) 0.83
Local control following therapeutic nodal dissection for melanoma. J Surg Oncol (1993) 0.82
Protein phosphatase 2A protects centromeric sister chromatid cohesion during meiosis I. Nature (2006) 3.81
Catalytic assembly of the mitotic checkpoint inhibitor BubR1-Cdc20 by a Mad2-induced functional switch in Cdc20. Mol Cell (2013) 2.06
Relationship between increased serum resistin level and severity of coronary artery disease. Angiology (2013) 2.00
Hepatic steatosis is associated with higher incidence of liver metastasis in patients with metastatic breast cancer; an observational clinical study. J BUON (2015) 1.97
Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study. J BUON (2015) 1.97
As a new inflammatory marker for familial Mediterranean fever: neutrophil-to-lymphocyte ratio. Inflammation (2013) 1.83
Structure and function of the PP2A-shugoshin interaction. Mol Cell (2009) 1.66
Survival results and prognostic factors in T4 N0-3 non-small cell lung cancer patients according to the AJCC 7th edition staging system. Asian Pac J Cancer Prev (2014) 1.52
Opportunistic cytomegalovirus infection in a patient receiving temozolomide for treatment of malignant glioma. J Clin Neurosci (2009) 1.44
Temozolomide in newly diagnosed malignant gliomas: administered concomitantly with radiotherapy, and thereafter as consolidation treatment. Onkologie (2008) 1.44
The influence of Helicobacter pylori eradication on leptin, soluble CD40 ligand, oxidative stress and body composition in patients with peptic ulcer disease. Intern Med (2009) 1.44
Total phenolic content, antioxidant and antimicrobial activities of some medicinal plants. Pak J Pharm Sci (2009) 1.43
How to interpret serum CA 125 levels in patients with serosal involvement? A clinical dilemma. Oncology (2003) 1.41
Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells. Int Immunopharmacol (2009) 1.37
Synchronous testicular liposarcoma and prostate adenocarcinoma: a case report. Cases J (2010) 1.33
The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment. Med Oncol (2009) 1.33
Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int J Clin Oncol (2014) 1.27
Primary renal carcinoid: treatment and prognosis. Crit Rev Oncol Hematol (2013) 1.20
Metaplastic breast carcinoma: case series and review of the literature. Asian Pac J Cancer Prev (2012) 1.18
Role of duplex power Doppler ultrasound in differentiation between malignant and benign thyroid nodules. Korean J Radiol (2010) 1.10
The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer. Hepatogastroenterology (2010) 1.09
Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection. Ann Surg Oncol (2010) 1.08
Serum leptin concentration and advanced gastrointestinal cancers: a case controlled study. BMC Cancer (2004) 1.06
Pulmonary artery sarcoma masquerading as chronic pulmonary thromboembolism. Tex Heart Inst J (2014) 1.03
A clinical, radiographic and laboratory evaluation of prognostic factors in 363 patients with malignant pleural mesothelioma. Respiration (2010) 1.02
Acute pancreatitis attributed to the use of pegylated interferon in a patient with chronic hepatitis C. J Gastrointestin Liver Dis (2007) 1.02
Serum gamma-glutamyltranspeptidase distinguishes non-alcoholic fatty liver disease at high risk. Hepatogastroenterology (2008) 1.02
Burnout in nurses and physicians working at an oncology department. Psychooncology (2009) 1.00
Prognostic factors for teenage and adult patients with high-grade osteosarcoma: an analysis of 240 patients. Med Oncol (2013) 0.99
Expression of transforming growth factor-beta-1 and p27Kip1 in pancreatic adenocarcinomas: relation with cell-cycle-associated proteins and clinicopathologic characteristics. BMC Cancer (2005) 0.99
Outcome of non-metastatic male breast cancer: 118 patients. Med Oncol (2011) 0.99
Prognostic importance of COX-2 expression in patients with colorectal cancer. Pathol Res Pract (2005) 0.98
Cytokeratin 5/6, c-Met expressions, and PTEN loss prognostic indicators in triple-negative breast cancer. Med Oncol (2013) 0.98
Assessment of right ventricular functions during cancer chemotherapy. Eur J Echocardiogr (2011) 0.97
Histiocytic sarcoma: PET-CT evaluation of a rare entity. Ann Nucl Med (2008) 0.97
Risk factors of nasopharyngeal carcinoma in Turkey-an epidemiological survey of the Anatolian Society of Medical Oncology. Asian Pac J Cancer Prev (2011) 0.97
Timing of death from tumor recurrence after curative gastrectomy for gastric cancer. Am J Clin Oncol (2004) 0.95
False Positive FDG PET/CT Resulting from Fibrous Dysplasia of the Bone in the Work-Up of a Patient with Bladder Cancer: Case Report and Review of the Literature. Iran J Radiol (2012) 0.95
Coronary flow velocity reserve and carotid intima media thickness in patients with autosomal dominant polycystic kidney disease: from impaired tubules to impaired carotid and coronary arteries. Clin J Am Soc Nephrol (2008) 0.94
Effects of preoperative chemoradiotherapy on anal sphincter functions and quality of life in rectal cancer patients. Int J Colorectal Dis (2009) 0.94
Primary adult soft tissue sarcomas: analysis of 294 patients. Med Oncol (2010) 0.94
Protective effects of nebivolol against anthracycline-induced cardiomyopathy: a randomized control study. Int J Cardiol (2012) 0.94
Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clin Exp Metastasis (2013) 0.94
Is the pretreatment neutrophil to lymphocyte ratio an important prognostic parameter in patients with metastatic renal cell carcinoma? Clin Genitourin Cancer (2012) 0.93
Co-existence of gastrointestinal stromal tumors with other primary neoplasms. Hepatogastroenterology (2011) 0.93
HGF/c-Met overexpressions, but not met mutation, correlates with progression of non-small cell lung cancer. Pathol Oncol Res (2011) 0.93
Bevacizumab plus irinotecan-based therapy in metastatic colorectal cancer patients previously treated with oxaliplatin-based regimens. Cancer Invest (2010) 0.93
Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer? Onkologie (2010) 0.92
Hyperthyroidism and thyroid autoimmunity induced by sorafenib in metastatic renal cell cancer. Endocrine (2012) 0.92
Breast cancer subtypes and outcomes of central nervous system metastases. Breast (2011) 0.92
Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer. Adv Ther (2008) 0.92
Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors. Med Oncol (2009) 0.92
Results after multivisceral resections of locally advanced colorectal cancers: an analysis on clinical and pathological t4 tumors. World J Surg Oncol (2012) 0.92
Coexistence of gastrointestinal stromal tumor (GIST) of the rectum and adenocarcinoma of the prostate in a patient with familial GIST. Onkologie (2008) 0.91
Serum CA 125 levels in patients with chronic heart failure and accompanying pleural fluid. Tumour Biol (2003) 0.91
Cardiotoxicity of de Gramont's regimen: incidence, clinical characteristics and long-term follow-up. Jpn J Clin Oncol (2005) 0.91
Inhibitory effect of 5-fluorouracil on cytochrome P450 2C9 activity in cancer patients. Basic Clin Pharmacol Toxicol (2006) 0.90
Quality of life, anxiety, and depression in Turkish colorectal cancer patients. Support Care Cancer (2009) 0.90
Childhood, adolescents, and young adults (≤25 y) colorectal cancer: study of Anatolian Society of Medical Oncology. J Pediatr Hematol Oncol (2013) 0.90
Protective effects of spironolactone against anthracycline-induced cardiomyopathy. Eur J Heart Fail (2014) 0.90
Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer. Med Oncol (2007) 0.89
Complications and toxicities after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol (2013) 0.89
Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer. Clin Appl Thromb Hemost (2011) 0.89
Prognostic factors and clinical outcome of patients with Ewing's sarcoma family of tumors in adults: multicentric study of the Anatolian Society of Medical Oncology. Med Oncol (2013) 0.89
Whole body 18F-FDG PET/CT imaging in the detection of primary tumours in patients with a metastatic carcinoma of unknown origin. Asian Pac J Cancer Prev (2009) 0.89
Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy. Int J Colorectal Dis (2007) 0.88
The impact of early percutaneous endoscopic gastrostomy placement on treatment completeness and nutritional status in locally advanced head and neck cancer patients receiving chemoradiotherapy. Eur Arch Otorhinolaryngol (2011) 0.88
FDG PET/CT appearance of portal vein tumor thrombus in the gastric primitive neuroectodermal tumor: uncommon primary tumor site with rare finding. Clin Nucl Med (2013) 0.88
Gastric carcinoma during pregnancy: report of a case. Turk J Gastroenterol (2007) 0.88
Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer. Med Oncol (2009) 0.88
Expression and prognostic significance of Cox-2 and p-53 in Hodgkin lymphomas: a retrospective study. Diagn Pathol (2010) 0.88
The effects of hematological parameters and tumor-infiltrating lymphocytes on prognosis in patients with gastric cancer. Cancer Biomark (2013) 0.88
Albumin-globulin ratio for prediction of long-term mortality in lung adenocarcinoma patients. Asian Pac J Cancer Prev (2014) 0.88
Results of adjuvant FOLFOX regimens in stage III colorectal cancer patients: retrospective analysis of 667 patients. Oncology (2013) 0.87
Prognostic factors for overall survival in patients with metastatic colorectal carcinoma treated with vascular endothelial growth factor-targeting agents. Asian Pac J Cancer Prev (2012) 0.87
Risk factors influencing mortality related to Stenotrophomonas maltophilia infection in hematology-oncology patients. Int J Hematol (2013) 0.87